Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 9/20 | 0.57 |
| ▸ | CYP11B2 | P19099 | 9/20 | 0.57 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.57 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | DHODH | Q02127 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19167058 | 1.00 | CYP11B1 (0.57) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19168305 | 0.96 | CYP11B1 (0.54) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19167057 | 0.96 | CYP11B1 (0.54) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19168348 | 0.95 | CYP11B1 (0.57) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19168330 | 0.95 | CYP11B1 (0.57) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19167740 | 0.95 | CYP11B1 (0.57) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19168326 | 0.93 | CYP11B1 (0.59) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19166436 | 0.92 | CYP11B1 (0.53) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19167079 | 0.92 | CYP11B1 (0.53) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL19167076 | 0.92 | DHODH (0.51) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10797244-B2 | Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2020-10-06 | — | — | US | disclosed |
| US-20170213982-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-07-27 | — | — | US | disclosed |
| US-20170213982-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10797244-B2 | Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device | RER1, RBM12, H1-2 | CYP11B1 2171/4885CYP11B2 1731/4885CYP19A1 716/4885 |
| US-20170213982-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | RER1, RBM12, H1-2 | CYP11B1 2171/4885CYP11B2 1731/4885CYP19A1 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.